Stimulation of Glutathione Peroxidase Activity Decreases HIV Type 1 Activation after Oxidative Stress

AIDS Research and Human Retroviruses

Volumn 10, Issue 11, 1994, Pages 1451-1461

  Sappey, Christine ^a,b   Legrand Poels, Sylvie ^a   Best Belpomme, Martin ^c   Favier, Alain ^b   Rentier, Bernard ^a   Piette, Jacques ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIV GRENOBLE ALPES   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTHERMIA; OXIDATIVE STRESS; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INACTIVATION;

ANTIOXIDANTS; CELL LINE; DNA, VIRAL; GLUTATHIONE PEROXIDASE; HEAT; HIV INFECTIONS; HIV-1; HUMAN; HYDROGEN PEROXIDE; NF-KAPPA B; OXIDATION-REDUCTION; OXIDATIVE STRESS; SELENIUM; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR;

EID: 0027937824     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.1994.10.1451     Document Type: Article

References (69)

1. Clerici M, Stocks NI, Zajac RA, Boswell RN, Lucey DR, Via CS, and Shearer GM: Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virusseropositive patients. J Clin Invest 1989; 84: 1892–1899.
2. Cuthbert RJG, Ludham CA, Tucker J, Steel CM, Beatson D, Rebus S, and Peutherer JF: Five years of prospective study of HIV infection in the Edinburgh haemophiliac cohort. Br Med J 1990; 301: 956–961.
3. Philips AN, Lee CA, Elford J, Janossy G, Timms A, Bofill M, and Kernoff PBA: Serial CD4 lymphocyte counts and development of AIDS. Lancet 1991; 337: 389–392.
4. Centers for Disease Control: Acquired immunodeficiency syndrome (AIDS), interim proposal for a WHO staging system for HIV infection and disease. WHO Wkly Epidemiol Rec 1990; 29: 221–224.
5. Levy JA: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993; 57: 183–289.
6. Staal FJT, Ela SW, Roederer M, Anderson MT, Herzenberg LA, and Herzenberg LA: Glutathione deficiency and human immunodeficiency virus infection. Lancet 1992; 339: 909–912.
7. Mihm S, Ennen J, Pessara U, Kurth R, and Droge W: Inhibition of HIV-1 replication and NF-κB activity by cysteine and cysteine derivatives. AIDS 1991; 5: 497–503.
8. Ho W-Z and Douglas SD: Glutathione and iV-acetylcysteine suppression of HIV replication in human monocytes/macrophages in vitro. AIDS Res Hum Retroviruses 1992; 8: 1249–1253.
9. Roederer M, Raju PA, Staal FJT, Herzenberg LA, and Herzenberg LA: iV-Acetylcysteine inhibits latent HIV expression in chronically infected cells. AIDS Res Hum Retroviruses 1991; 7: 563–567.
10. Eck H-P, Gmunder H, Hartmann M, Petzoldt D, Daniel V, and Droge W: Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1 infected patients. Biol Chem Hoppe-Seyler 1989; 370: 101–107.
11. Buhl R, Holroyd KJ, Mastrangeli A, Cantin AM, Jaffe HA, Wells FB, Saltini C, and Crystal RG: Systemic glutathione deficiency in symptom free HIV-seropositive individuals. Lancet 1989; 2: 1294–1296.
12. Staal FJT, Roederer M, Israelski DM, Bubp J, Mole LA, McShane D, Derersinski SC, Ross W, Sussman H, Raju PA, Anderson MT, Moore W, Ela SW, Herzenberg LA, and Herzenberg LA: Intracellular glutathione levels in T cell subsets decrease in HIV infected individuals. AIDS Res Hum Retroviruses 1992; 8: 305–311.
13. Legrand-Poels S, Vaira D, Pincemail J, van de Vorst A, and Piette J: Activation of human immunodeficiency virus type 1 by oxidative stress. AIDS Res Hum Retroviruses 1990; 6: 1389–1397.
14. Schreck R, Rieber P, and Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of NFkB transcription factor and HIV-1. 1. EMBO J 1991; 10: 2247–2258.
15. Schreck P, Meier B, Mannel DM, Droge W, and Baeuerle PA: Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 1992; 175: 1181–1194.
16. Roederer M, Staal FJT, Raju PA, Ela SW, Herzenberg LA, and Herzenberg LA: Cytokine-stimulated HIV replication is inhibited by /V-acetyl-L-cysteine. Proc Nati Acad Sci USA 1990; 87: 4884–4888.
17. Kabelic T, Kinter A, Poli G, Anderson ME, Meister A, and Fauci AS: Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and IV-acetylcysteine. Proc Nati Acad Sci USA 1991; 88: 986–990.
18. Sandstrom PA, Roberts B, Folks TM, and Buttke TM: HIV gene expression enhances T cell susceptibility to hydrogen peroxide-induced apoptosis. AIDS Res Hum Retroviruses 1993; 9: 1107–1113.
19. Sandstrom PA and Buttke TM: Autocrine production of extracellular catalase prevents apoptosis of the human CEM T cell line in serum free media. Proc Nad Acad Sci USA 1993; 90: 4708–4712.
20. Lee PC, Bochner BR, and Ames BM: AppppA, heat shock stress, and cell oxidation. Proc Nati Acad Sci USA 1983; 80: 7496–7500.
21. Ropp M, Courgeon AM, Calvayrac R, and Best-Belpomme M: The possible role of the Superoxide ion in the induction of heat shock and specific proteins in aerobic Drosophila cells during return to normoxia after a period of anaerobiosis. Can J Biochem Cell Biol 1983; 61: 456–461.
22. Becker J, Mezger V, Courgeon AM, and Best-Belpomme M: Hydrogen peroxide activates immediate binding of a Drosophila factor to DNA heat-shock regulatory element in vivo and in vitro. Eur J Biochem 1990; 189: 553–558.
23. Linquist S: The heat-shock response. Annu Rev Biochem 1986; 55: 1151–1191.
24. Bienz M and Pelham HRB: Mechanism of heat-shock activation in highe eukaryotes. Adv Genet 1987; 24: 31–72.
25. Burel C, Mezger V, Pinto M, Rallu M, Trigon S, and Morange M: Mammalian heat shock protein families: Expression and functions. Experientia 1992; 48: 629–635.
26. Haseltine W: Control of Human Retrovirus Gene Expression. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1988.
27. Nabel G and Baltimore D: An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 1987; 326: 711–713.
28. Siekevitz M, Josephs SH, Dukovitch M, Peffer N, Wong-Staal F, and Greene WC: Activation of the HIV LTR by cell mitogens and the trans-activation protein of HTLV-1. Science 1987; 238: 1575–1578.
29. Baeuerle PA: The inducible transcription activator NF-κB: Regulation by distinct protein subunits. Biochim Biophys Acta 1991; 1072: 63–80.
30. Baeuerle PA and Baltimore D: IkB: A specific inhibitor of the NF-κB transcription factor. Science 1988; 242: 540–546.
31. Ghosh S and Baltimore D: Activation in vitro of NF-κB by phosphorylation of its inhibitor IkB. Nature (London) 1990; 344: 678–682.
32. Lenardo MJ and Baltimore D: NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control. Cell 1989; 58: 227–229.
33. Horvat RT and Wood CJ: Promoter activity in primary antigenspecific human T lymphocytes. J Immunol 1989; 132: 2745–2751.
34. Hazan U, Thomas D, Alcami J, Bachelerie F, Israel N, Yssel Y, Virelizier JL, and Arenzana-Seisdedos F: Stimulation of a human T-cell clone with an anti-CD3 or tumor necrosis factor induces NF-κB translocation but not human immunodeficiency virus-1 enhancer-dependent transcription. Proc Nad Acad Sci USA 1990; 87: 7861–7865.
35. Tong-Starksen S, Luciw PA, and Peterlin BM: Signaling through T lymphocyte surface protein TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. J Immunol 1989; 142: 702–707.
36. Folks TM, Justement J, Kinter A, Schnittman S, Orenstein J, Poli G, and Fauci AS: Characterization of a promonocyte clone chronically infected with HIV-1 and inducible by 13-phorbol-12-myristate acetate. J Immunol 1988; 140: 1117–1122.
37. Clouse KA, Powell D, Washington I, Poli G, Strebel K, Farrar W, Barstad P, Kovacs J, Fauci AS, and Folks TM: Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J Immunol 1989; 142: 431–438.
38. Virelizier JL: Cellular activation and human immunodeficiency virus infection. Curr Opin Immunol 1990; 2: 409–413.
39. Henkel T, Machleidt, Alkalay I, Krönke M, Ben-Neriah Y, and Baeuerle PA: Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature (London) 1993; 365: 182–185.
40. Grilli M, Chiu JS, and Lenardo MJ: NF-κB and Rel: Participants in a multiform transcriptional regulatory system. Int Rev Cytol 1993; 143: 1–62.
41. Flohe L: Glutathione-peroxidase brought into focus. In: Free Radicals in Biology. Pryor WA (Ed.). Academic Press, New York, 1982, pp. 223–254.
42. Prohaska JR: The glutathione-peroxidase activity of glutathione-Stransferases. Biochim Biophys Acta 1980; 611: 87–98.
43. Mannervik B: Glutathione peroxidase. Methods Enzymol 1985; 113: 490–495.
44. Speier S, Baker SS, and Newberger PE: Relationship between in vitro selenium supply, glutathione peroxidase activity, and phagocytic function in the HL-60 human myeloid line. J Biol Chem 1985; 260: 8951–8955.
45. Suttorp N and Simon LN: Importance of the glutathione redox cycle for resistance of lung epithelial cells against polymorphonuclear leukocyte-mediated oxidant attack. Biochem Pharmacol 1986; 35: 2268–2270.
46. Thomas JP and Girotti AW: Role of lipid peroxidation in hematoporphyrin derivative-sensitized photokilling of tumor cells: Protective effects of glutathione peroxidase. Cancer Res 1989; 49: 1682–1686.
47. Geiger PG, Thomas JP, and Girotti AW: Lethal damage to murine L1210 cells by exogenous lipid hyperoxides: Protective role of glutathione-dependent selenoperoxidases. Arch Biochem Biophys 1991; 288: 671–680.
48. Olmsted L, Schrauzer GN, Flores-Arce M, and Dowd J: Selenium supplementation of symptomatic human immunodeficiency virus infected patients. Biol Trace Elem Res 1989; 20: 59–65.
49. Dworkin BM, Rosenthal WS, and Wormser GP: Abnormalities of blood selenium and glutathione peroxidase activity in patients with acquired immunodeficiency syndrome and AIDS-related complex. Biol Trace Elem Res 1988; 15: 167–177.
50. Gunzler WA, Kremers H, and Flohe L: An improved coupled test procedure for glutathione peroxidase in blood. Z Chem Klin Biochem 1974; 12: 444–448.
51. Hoffman AD, Banapour B, and Levy JA: Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 1985; 147: 326–335.
52. Andrews NC and Faller DV: A rapid micropreparation technique for extraction of DNA binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 1991; 19: 2499.
53. Dignam D, Lebovitz RM, and Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983; 11: 1475–1489.
54. Meyer M, Schreck R, and Baeuerle PA: H202 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 1993; 12: 2005–2015.
55. Lowenthal JW, Ballard DW, Böhnlein E, and Greene WC: Tumor necrosis factor α induces proteins that bind specifically to κB-like enhancer elements and regulate interleukin 2 receptor α-chain genes expression in primary human T lymphocytes. Proc Nati Acad Sci USA 1989; 86: 2331–2335.
56. Forman HJ and Boveris A: Superoxide radicals and hydrogen peroxide in mitochondria. In: Free Radicals in Biology. Pryor WA (Ed.). Academic Press, New York, 1982, pp. 233–254.
57. Hockenbergy DM, Oltvai ZN, Yin X-M, Milliman CL, and Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241–251.
58. Klein J: Immunology. Blackwell Scientific, Boston, 1990, pp. 1–353.
59. Roederer M, Ela SW, Staal FJT, Herzenberg LA, and Herzenberg LA: JV-Acetylcysteine: A new approach to anti-HIV therapy. AIDS Res Hum Retroviruses 1992; 8: 209–217.
60. Aruoma OI, Halliwell B, Hoey BM, and Buttler J: The antioxidant action of iV-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, Superoxide, and hypochlorous acid. Free Radie Biol Med 1989; 6: 593–597.
61. Moldeus P, Cotgreave IA, and Berggren M: Lung protection by a thiol-containing antioxidant: Ai-Acetylcysteine. Respiration 1986; 50(Supplement 1)31.
62. Geiger PG, Lin F, and Girotti AW: Selenoperoxidase-mediated cytoprotection against the damaging effects of (ert-butyl hydroperoxide on leukemia cells. Free Radie Biol Med 1993; 14: 251–266.
63. Richard MJ, Frappat P, Arnaud J, and Favier A: Selenium and glutathione peroxidase activity in diploid human fibroblasts: Their effects against H202 and UVB induced toxicity. In: Antioxidants in Therapy and Preventive Medicine. Emerit I (Ed.). Plenum Press, New York, 1992, pp. 179–182.
64. Urban T and Jarstrand C: Selenium effects on human neutrophilic granulocyte function in vitro. Immunopharmacology 1986; 12: 167–172.
65. Staal FJT, Roederer M, Raju PA, Anderson MT, Ela SW, Herzenberg LA, and Herzenberg LA: Antioxidants inhibit stimulation of HIV transcription. AIDS Res Hum Retroviruses 1993; 9: 299–306.
66. Devary Y, Gottlieb RA, Lau LF, and Karin M: Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol Cell Biol 1991;11: 2804–2811.
67. Cross AR and James OTG: Enzymic mechanisms of Superoxide production. Biochim Biophys Acta 1991; 1057: 281–298.
68. Jöbsis FF: Mitochondrial respiration. In: Handbook of Physiology, Vol. 1. Fenn WO and Rahn H (Eds.). American Physiology Society, Washington, D.C., 1964, pp. 63–124.
69. Kane DJ, Sarafian TA, Anton R, Hahn H, Buler Gralla E, Selverstone J, Ord T, and Bredesen DE: Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 1993; 262: 1274–1277.